Novel MRI and 1H-MRS markers in Primary Progressive MS
Novel MRI and 1H-MRS markers in Primary Progressive MS
批准号:
7560399
负责人:
Matilde INGLESE
金额:
$27.92万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2011-01-14
关键词:
AgeApoptosisBloodBlood VesselsBrainBrain PathologyCerebrospinal FluidCerebrovascular CirculationChildCholineClinicalClinical TrialsCognitiveCreatineDataDeteriorationDevelopment PlansDiffuseDiseaseDisease ProgressionFaceFailureGenderGliosisImpairmentInflammationInjuryInositolLaboratoriesLeadLesionLettersLiteratureMagnetic Resonance ImagingMagnetic Resonance SpectroscopyManuscriptsMeasuresMetabolicMethodsMetricMicroscopicMinorityMonitorMultiple SclerosisNeurologicNeuronsNeuropsychological TestsOligodendrogliaOutcome MeasurePatientsPerformancePerfusionPhasePlayPredispositionPrimary Progressive Multiple SclerosisProgress ReportsProtonsPublicationsRandomized Controlled Clinical TrialsRelapseRelapsing-Remitting Multiple SclerosisResearchResearch DesignResearch PersonnelResourcesRoleSafetySeveritiesTechniquesTestingTimeVertebratesWeightWomanbrain tissuebrain volumecohortdisabilityhuman subjecthuman subject protectionnovelnovel markeroutcome forecastpatient populationproduct developmentprogramsreceptorrepairedtime use
中文摘要
四页)
其他传记小品(每份不超过四页-见说明书)
资源33
研究计划。33
修订申请简介(不超过3页)33
补充申请简介(不超过一页)N/A
A.具体目标36
B.背景和意义37
C.初步研究/进度报告/(项目A-D:不超过25页*)44
第一阶段进度报告(仅限于SBIR/STTR第二阶段)*SBIR/STTR第一阶段:项目A-D,限于15页。
D.研究设计和方法50
E.人体受试者58
保护人类受试者(如正面第4项标记为“是”,则为必填项)58
包括妇女(如正面第4项标记为“是”,则为必填项)_58
包括少数族裔(如首页第4项标记为“是”,则为必填项)_58
包括儿童(如首页第4项标记为“是”,则为必填项)58
数据和安全监测计划(如果页面上的第4项标记为是且为I、II或III期临床,则为必填项
建议进行试验
F.脊椎动物60
G.引用文献60篇
H.联合体/合同安排66
一、支持函(如顾问)68
J.产品开发计划(仅限SBIR/STTR第二阶段和快速通道)N/A
核对表。69
检查是否
附录(五个整理集。附录中不需要编号。)
附录为
包括在内
除非特别请求,否则第一阶段SBIR/STTR不允许使用附录...
接受出版的出版物和稿件数量(注:超过10篇)
其他项目(列表):
支持函:约翰·德卢卡教授,顾问
小灵通398(05/01版)页表单第3页
使用/2英寸页边距。在整个应用程序的底部连续编号页码。不要使用3a、3b等后缀。
英文摘要
four pages)
Other Biographical Sketches (Not to exceed four pages for each - Seeinstructions)
Resources 33
Research Plan. 33
Introduction to Revised Application (Not to exceed 3 pages) 33
Introduction to Supplemental Application (Not to exceed one page) N/A
A. Specific Aims 36
B. Background and Significance 37
C. Preliminary Studies/Progress Report/ (Items A-D: not to exceed 25 pages*) 44
Phase I Progress Report (SBIR/STTR Phase II ONLY) * SBIR/STTR Phase I: Items A-D limited to 15 pages.
D. Research Design and Methods 50
E. Human Subjects 58
Protection of Human Subjects (Required if Item 4 on the Face Page is marked "Yes") 58
Inclusion of Women (Required if Item 4 on the Face Page is marked "Yes") _58
Inclusion of Minorities (Required if Item 4 on the Face Page is marked "Yes") _58
Inclusion of Children (Required if Item 4 on the Face Page is marked "Yes") 58
Data and Safety Monitoring Plan (Required if Item 4 on the Face Page is marked "Yes" and a Phase I, II, or III clinical
trial is proposed
F. Vertebrate Animals 60
G. Literature Cited 60
H. Consortium/Contractual Arrangements 66
I. Letters of Support (e.g., Consultants) 68
J. Product Development Plan (SBIR/STTR Phase II and Fast-Track ONLY) N/A
Checklist. 69
Check if
Appendix (Five collatedsets. Nopage numbering necessary for Appendix.)
Appendix is
Included
Appendices NOT PERMITTED for Phase I SBIR/STTR unless specifically solicited....
Number of publications and manuscripts accepted for publication (notto exceed10)
Other items (list):
1. Letter of support: Prof. John DeLuca, consultant
PHS 398 (Rev. 05/01) Page. Form Page 3
Use /2-inch MARGINS. Number pages consecutively at the bottom throughout the application. Do not use suffixes such as 3a, 3b.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI predictors of disease and disability progression in African Americans with multiple sclerosis
-
批准号:9446084
-
项目类别:
-
资助金额:$54.89万
-
财政年份:2017
-
负责人:Matilde INGLESE
-
依托单位:
Examining the role of brain sodium content in multiplesclerosis using MRI
-
批准号:9381282
-
项目类别:
-
资助金额:$59.01万
-
财政年份:2017
-
负责人:Matilde INGLESE
-
依托单位:
Non-invasive Brain Sodium Quantification in Multiple Sclerosis
-
批准号:8926893
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2014
-
负责人:Matilde INGLESE
-
依托单位:
Novel MRI and 1H-MRS markers in Primary Progressive MS
-
批准号:7039294
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2006
-
负责人:Matilde INGLESE
-
依托单位:
Novel MRI and 1H-MRS markers in Primary Progressive MS
-
批准号:7345394
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2006
-
负责人:Matilde INGLESE
-
依托单位:
Novel MRI and 1H-MRS markers in Primary Progressive MS
-
批准号:7160501
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2006
-
负责人:Matilde INGLESE
-
依托单位:
Novel MRI and 1H-MRS markers in Primary Progressive MS
-
批准号:8259346
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2006
-
负责人:Matilde INGLESE
-
依托单位:
Novel MRI markers in progressive Multiple Sclerosis
-
批准号:8329900
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2005
-
负责人:Matilde INGLESE
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: